VSee Health Inc. Announces Planned 80‑for‑1 Reverse Stock Split to Protect Shareholder Value

VSee Health Inc. (NASDAQ: VSEE) disclosed on July 22, 2026 that it will pursue a reverse stock split with a maximum ratio of 80‑for‑1. The Board has approved the plan, subject to regulatory and shareholder approvals, as a measure to realign the company’s capital structure, maintain its Nasdaq listing, and minimize dilution.

Key Details of the Reverse Split

  • Maximum Ratio: 80‑for‑1 (previously indicated up to 250‑for‑1, now capped at 80‑for‑1).
  • Objective: Align share price with Nasdaq’s listing requirements and enhance perceived value for investors.
  • Share Outstanding: 55,679,813 shares as of July 6, 2026.
  • Timing: Proposal will be presented to shareholders at the forthcoming Annual Meeting.

Financial Strategy Adjustments

In tandem with the reverse split, VSee Health terminated its standby equity purchase agreement, thereby eliminating a potential source of near‑term dilution. The company has also strengthened its balance sheet over the last 45 days through non‑dilutive financing, reinforcing its financial flexibility.

“Our goal is to minimize shareholder dilution while strengthening our balance sheet and investing in the continued growth of our business,” said Dr. Imoigele Aisiku, Chairman and Chief Executive Officer. “The reverse split will be the lowest ratio necessary to satisfy Nasdaq’s requirements while preserving shareholder value.”

Market Context

  • Current Share Price (July 21, 2026): $0.08, the 52‑week low.
  • 52‑Week Range: $0.0777 – $2.52.
  • Market Capitalization: $4.47 million.
  • Price/Earnings Ratio: –0.23, reflecting the company’s ongoing investment phase.

The reverse split is a strategic tool commonly employed by companies with low share prices to maintain compliance with exchange listing standards and to create a more attractive investment proposition for market participants. By limiting the split ratio to 80‑for‑1, VSee Health demonstrates a cautious approach that balances regulatory compliance with shareholder equity protection.

Forward‑Looking Perspective

VSee Health’s decision to pursue a reverse split, while terminating the equity purchase agreement, signals a commitment to sustaining a lean capital structure. This approach is expected to provide the company with greater flexibility to fund growth initiatives in the telehealth sector—particularly its API‑driven virtual care platform that integrates secure video, device data, and EHR connectivity across U.S. hospitals and health networks.

Investors should monitor the outcome of the shareholder vote and the subsequent regulatory approvals, as these will determine the timing and execution of the reverse split. The company’s continued emphasis on minimizing dilution while investing in scalable digital health solutions positions it to capitalize on the accelerating shift toward high‑acuity virtual care.